In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria

Nicolas C. Issa, Mark S. Rouse, Kerryl E. Piper, Walter R. Wilson, James M. Steckelberg, Robin Patel

Research output: Contribution to journalArticle

42 Scopus citations

Abstract

The minimum inhibitory concentration and minimum bactericidal concentration of BAL9141 against 150 clinical isolates of gram-negative bacteria were determined and compared to those of cefepime and ceftriaxone. BAL9141 exhibited comparable activity to cefepime and ceftriaxone against Haemophilus influenzae, Klebsiella pneumoniae, and extended-spectrum β-lactamase nonproducing Enterobacter cloacae, and comparable activity to cefepime against Pseudomonas aeruginosa.

Original languageEnglish (US)
Pages (from-to)73-75
Number of pages3
JournalDiagnostic Microbiology and Infectious Disease
Volume48
Issue number1
DOIs
StatePublished - Jan 2004

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria'. Together they form a unique fingerprint.

  • Cite this